人胚胎脐血间质干细胞生物学特性研究  

Biological characterics of human fetal cord blood mesenchymal stem cells

作　　者：朱美玲[1] 那晓东[1] 雷俊霞[1] 刘华 胡燕芬 黄玲惠 黄伟花[3] 张秀明[1] 李树浓[1] 

机构地区：[1]中山大学中山医学院病理生理学教研室 [2]深圳市宝安区血站脐血库 [3]深圳市宝安区西乡人民医院

出　　处：《中国病理生理杂志》2004年第6期1003-1008,共6页Chinese Journal of Pathophysiology

基　　金：国家重点基础研究项目 (No .2 0 0 1CB5 0 990 4 );广东省十五重大攻关项目资助 (2 0 0 1A30 2 0 10 1)

摘　　要：目的 :研究人中期胚胎脐血间质干细胞生物学特性 ,探讨其在自体宫内基因转移 /治疗 (IUGT)领域的应用前景。方法 :采用L -DMEM完全培养液培养中期胚胎脐血间质干细胞 (MSC) ;流式细胞仪技术检测细胞表面标记 ;地塞米松 /胰岛素等作为脂肪细胞诱导液 ,β -甘油磷酸钠 /抗坏血酸等作为成骨细胞诱导液分别诱导细胞分化 ;将携带有绿色荧光蛋白的重组腺病毒转染MSC ,荧光显微镜下检测MSC表达转基因特性 ;F344新生大鼠肝内注射MSC ,免疫荧光检测 6周后不同组织器官中人MSC存在 ;非肥胖型糖尿病 /重症联合免疫缺陷性小鼠 (NOD/SCID)皮下注射MSC ,病理切片检测第 30d细胞体内成瘤性。结果 :3mL人中期胚胎脐血可以分离、培养出MSC ,细胞均一地表达CD2 9、CD4 4、CD5 9、CD10 5、CD16 6 ,不表达CD34、CD4 5、CD80、CD86、CD4 2a、HLA -DR分子 ,体外培养中具有成脂、成骨能力 ;细胞表达转基因产物绿色荧光蛋白阳性率高达 5 6 32 %± 3 2 8% ;在新生大鼠体内 ,人中期胚胎脐血来源的MSC能向多个不同组织器官迁移 ,在NOD/SCID小鼠内不具有成瘤性。结论 :人中期胚胎脐血MSC适合中、晚期胚胎自体IUGT靶细胞。AIM: To investigate the biological characterics of human second-trimester fetal cord blood mesenchymal stem cells (MSC) and its application prospects in utero gene transfer/therapy (IUGT). METHODS: Nuclear cells separated from cord blood were cultured in DMEM medium. Surface antigens of the MSC were analyzed by the FACScan flow cytometry. Adipogenic and osteogenic mediums were used to assess the differentiation ability of the cells. Adenovirus vector deliver green fluorescent protein gene (Ad-GFP) was used to transfected the MSC and the expressing of GFP was detected by fluorescent microscope. The MSC were injected into the liver of newborn rat. The immunofluorescence analysis was conducted to determine the presence of double-positive CD105+/CD166+ cells in different organs of rats. MSC were subcutaneous injected into the human-nonobese diabetes/severe combined immunodeficiency disease (NOD/SCID) mice and carcinogenesises of the MSC in vivo were detected by pathological diagnosis. RESULTS: MSC could be separated from fetal cord blood. These cells were uniformly positive for CD29, CD44, CD59, CD105, CD166 and negative for CD34, CD45, CD80, CD86, HLA-DR. The cells had the abilities to differentiate into adipogenic and osteogenic cells in vitro, expressed the GFP at high levels (56 32%±3 28%). The MSC were located at different organs after injected into the newborn rats and didn't have carcinogenicity in vivo. CONCLUSION: Human second-trimester fetal cord blood MSC is an promising target cells in fetal IUGT.

关 键 词：胎血 间质干细胞 基因疗法 基因转移 水平 

分 类 号：R363[医药卫生—病理学]